Effect of repaglinide or sitagliptin upon glycemic control in Japanese patients with type 2 diabetes mellitus.
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000008474
- Lead Sponsor
- Kawasaki Medical School Hospital
- Brief Summary
Per test planner retirement
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Type1 diabetes mellitus. 2) Patients with serious ketosis, diabetic coma, or pre-coma. 3) Patients with severe infection, before and after surgery, or severe injury. 4) Patients with pregnancy or lactating. 5) Patients with severe hepatic dysfunction. 6) Patients with renal impairment. 7) Patients treated with insulin. 8) Patients who has a history of adverse events with each drugs. 9) Patients who has a history of hypersensitivity to each drugs. 10) Patients who are judged unsuitable to participate the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c(NGSP) 1,5AG 8-iso-prostaglandin F2a
- Secondary Outcome Measures
Name Time Method